Noticias de CELC_US

Noticias del mercado

Últimas noticias sobre CELC_US — 208 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CELC_US ✕ 208 resultados
14/05/2026 CELC_US — Yahoo Finance
Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients
14/05/2026 CELC_US — Benzinga
Transcript: Celcuity Q1 2026 Earnings Conference Call
14/05/2026 CELC_US — The Globe and Mail
Celcuity Inc. Reports Release of First Quarter 2026 Financial Results and Provides Corporate Update
14/05/2026 CELC_US — GlobeNewswire
Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a
14/05/2026 CELC_US — MarketScreener
Celcuity Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
14/05/2026 CELC_US — Investing.com
Celcuity expands phase 3 breast cancer trial design
14/05/2026 CELC_US — MarketScreener
Earnings Flash (CELC) Celcuity Inc. Posts Q1 Adjusted Loss $0.86 per Share, vs. FactSet Est of $-0.95
14/05/2026 CELC_US — MarketBeat
Celcuity Q1 2026 Earnings Call Transcript
14/05/2026 CELC_US — The Globe and Mail
Celcuity Q1 Earnings Call Highlights
14/05/2026 CELC_US — MarketScreener
Celcuity's phase 3 VIKTORIA-2 trial of gedatolisib as a first-line treatment for HR+/HER2- advanced breast cancer expanding to include endocrine-sensitive patients
14/05/2026 CELC_US — Investing.com Canada
Celcuity expands phase 3 breast cancer trial design By Investing.com
07/05/2026 CELC_US — Yahoo Finance
Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call
07/05/2026 CELC_US — GlobeNewswire
Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call
06/05/2026 CELC_US — Investing.com
Celcuity director Richard Buller sells $1.26 million in stock
05/05/2026 CELC_US — Yahoo Finance
Is It Too Late To Consider Celcuity (CELC) After A 13x One Year Surge?
04/05/2026 CELC_US — MSN
Wall Street believes Celcuity could become an acquisition target – why this analyst raised their price target by a whopping 76%
04/05/2026 CELC_US — MarketScreener
Celcuity Shares Climb on Positive Breast-Cancer Drug Trial Results
04/05/2026 CELC_US — BioWorld News
Celcuity rises on gedatolisib on top-line data in breast cancer
04/05/2026 CELC_US — Investing.com
Stifel raises Celcuity stock price target on trial data strength
04/05/2026 CELC_US — Quantisnow
Celcuity upgraded by H.C. Wainwright with a new price target

Página 9 de 11

keyboard_arrow_up